Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Breast Neoplasms 3Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1

Interventions

Glutamine 3Physical Therapy Modalities 2Acupuncture Therapy 2glutamic acid diethyl ester 1Thioctic Acid 1Sugars 1Pain Management 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Minocycline 1Low-Level Light Therapy 1Ketamine 1Glutamic Acid 1Exercise 1Epoetin Alfa 1Duloxetine Hydrochloride 1Dietary Supplements 1Biopsy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Peripheral Nervous System Diseases × Duloxetine Hydrochloride × Clear all
NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡